Reduction of Salt Intake During Converting Enzyme Inhibitor Treatment Compared With Addition of a Thiazide
Donald R. J. Singer(St George's, University of London), Graham A. MacGregor(Queen Mary University of London), Francesco P. Cappuccio(University Hospitals Coventry and Warwickshire NHS Trust), Michelle A. Miller(University of Warwick), Nirmala D. Markandu(University of London), Giuseppe A. Sagnella(Charing Cross Hospital)
Cited by 49
Related Papers
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
|The Lancet Diabetes & Endocrinology|2018|340